Bandingkan Harga & Kinerja Bank Mandiri Persero Tbk (BMRI) vs UBC Medical Indonesia Tbk. (LABS)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bank Mandiri Persero Tbk dan UBC Medical Indonesia Tbk.: Bank Mandiri Persero Tbk diperdagangkan di Rp4.200 (kapitalisasi pasar 384,38 T, volume 24 jam 145,28 jt), sedangkan UBC Medical Indonesia Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 584,6 M, volume 24 jam 817,3 rb). Perbedaan utamanya: Bank Mandiri Persero Tbk jauh lebih besar — sekitar 657,5× kapitalisasi pasar UBC Medical Indonesia Tbk., dan Bank Mandiri Persero Tbk lebih aktif diperdagangkan (145,28 jt vs 817,3 rb). Mana yang lebih baik tergantung tujuan investasimu.
| BMRI | LABS | |
|---|---|---|
Kapitalisasi Pasar | 384,38 T | 584,6 M |
Volume | 145,28 jt | 817,3 rb |
Lot | 1,45 jt | 8,17 rb |
Perputaran | 613,36 M | 120,01 jt |
Harga Rata-rata | 4.221,85 | 146,84 |
Nilai Transaksi | 613,36 M | 120,01 jt |
Harga Ekuilibrium Indikatif | 4.200 | 146 |
Volume Ekuilibrium Indikatif | 138,7 rb | 59 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bank Mandiri Persero Tbk
Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.
Selengkapnya di halaman BMRI →Tentang UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Selengkapnya di halaman LABS →
